Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2015/02/005556
CTRI/2015/02/005556
Completed
Phase 3

Clinical trial to assess the efficacy and safety of TNK-TPA in Acute Ischemic Stroke - TNK-TPA

Gennova Biopharmaceuticals Ltd0 sites62 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Gennova Biopharmaceuticals Ltd
Enrollment
62
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 28, 2016
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Acute ischemic stroke with serious measurable deficit on National Institute of Health Stroke Scale (NIHSS)
  • •2\.Treatment within 3 hours of stroke onset
  • •3\.Age 18 to 75 years
  • •4\.Patient or legally acceptable representative willing to give informed written consent before study procedure

Exclusion Criteria

  • •1\.Minor stroke symptoms, or major symptoms rapidly improving
  • •2\.Intracranial hemorrhage on pretreatment head computerised tomography (CT) scan
  • •3\.Clinical presentation suggesting subarachnoid haemorrhage
  • •4\.Pregnancy
  • •5\.Known bleeding diathesis and/or platelet count \< 100000 mm3
  • •6\.Patient taking oral anticoagulants
  • •7\.Patients who have received heparin within 48 hours
  • •8\.Major surgery or serious trauma within 14 days; serious head trauma within 3 months
  • •9\.Gastrointestinal or urinary tract hemorrhage within 21 days
  • •10\.Arterial puncture at a noncompressible site or lumbar puncture within 7 days

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Clinical trial of S-Metoprolol and Telmisartan combination tablet in the treatment of hypertensio
CTRI/2011/06/001819Emcure Pharmaceuticals Ltd Pune200
Completed
Phase 2
Clinical trial to assess the efficacy and safety of TNK-TPA in Acute Ischemic Stroke
CTRI/2009/091/000251Gennova Biopharmaceuticals Limited Pune50
Completed
Phase 3
Efficacy and safety of Fixed Dose Combination of Dexketoprofen Trometamol and Dicyclomine Hydrochloride Injectio
CTRI/2010/091/001343Emcure Pharmaceuticals Ltd. Pune200
Not yet recruiting
Not Applicable
Clinical trial to evaluate the safety, efficacy, and economic feasibility of virtual reality-based ‘Emotion to Emotion Therapy’ for post-traumatic stress disorder patients
KCT0007845Wonkwang University Sanbon Hospital72
Recruiting
Not Applicable
Clinical trial to verify the efficacy and safety of improvement of lower extremity muscle function and balance therapy using Electric Orthopedic Exercise Device(WALK WELL™) in hemiplegic stroke patients
KCT0004558Chonbuk National University Hospital30